Critical funding gap threatens health response in Yemen - UN News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Renewed clashes between Saudi-backed Yemeni Government forces and Houthi rebels supported by Iran, have intensified in recent weeks. More than 200,000 people have been displaced, according to latest figures from UN migration agency, IOM, while close to 3,800 have fled to Djibouti across the Red Sea. WHO said its immediate funding requirements have increased from $9 million to $31 million. An additional $700,000 is also needed to support refugees in Djibouti. “The situation is evolving into a complex emergency, with health needs rising as resources are already severely stretched,” said Dr. Syed Jaffar Hussain, WHO Representative in Yemen. Health services struggle to cope Fighting has mainly occurred on the coast in Lahj governorate in southwestern Yemen near the strategic Bab al-Mandeb Strait, in neighbouring Taiz governorate and in Marib governorate in northern Yemen. As of 2 October, there were 959 reported deaths and 4,207 injuries across 10 governorates, according to the Yemeni health authorities. Health services in conflict-affected governorates are struggling to cope with mounting needs.
This article is an excerpt. To read the full content, visit the original source. UN News
Related articles
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!